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Abstract
Moderate wine consumption has been shown to lower cardiovascular risk. One of the mechanisms could involve the control of postpran-
dial hyperlipaemia, a well-defined risk factor for atherosclerosis, reasonably by reducing the absorption of lipid oxidised species from the
meal. The objective of the present study was to investigate whether wine consumption with the meal is able to reduce the postprandial
increase in plasma lipid hydroperoxides and cholesterol oxidation products, in human subjects. In two different study sessions, twelve
healthy volunteers consumed the same test meal rich in oxidised and oxidisable lipids (a double cheeseburger), with 300 ml of water
(control) or with 300 ml of red wine (wine). The postprandial plasma concentration of cholesterol oxidation products was measured
by GC–MS. The control meal induced a significant increase in the plasma concentration of lipid hydroperoxides and of two cholesterol
oxidation products, 7-b-hydroxycholesterol and 7-ketocholesterol. The postprandial increase in lipid hydroperoxides and cholesterol
oxidation products was fully prevented by wine when consumed with the meal. In conclusion, the present study provides evidence
that consumption of wine with the meal could prevent the postprandial increase in plasma cholesterol oxidation products.
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Epidemiological studies have indicated that wine can be con-
sidered protective against CVD development when its moderate
consumption is inserted in a correct lifestyle(1), including
the ‘instructions to drink/use’, i.e. ‘to be taken with meals’.
A number of experimental studies have suggested that red
wine compounds, especially polyphenols, might play a role in
preventing the development and progression of atherosclerosis,
acting through different pathways that include inhibition of
lipid peroxidation, metal chelation, free-radical scavenging,
inhibition of platelet aggregation, anti-inflammatory and oestro-
genic activity, improvement of endothelial function, lowering of
blood pressure and modulation of lipoprotein metabolism(2).
The attenuation of postprandial oxidative stress could be one
of the mechanisms explaining the protective action of wine
phenols(3,4). In fact, the absorption of pro-oxidant/oxidised
species with the meal can induce physiological events, such as
the formation of mildly oxidised lipoprotein(5) or endothelial
dysfunction(6), and inflammatory responses(7), all events
linked to the development of CVD.
There is evidence that oxycholesterols are angiotoxic and
could cause atherosclerosis(8). Animal studies have shown
that the addition of oxidised cholesterol to the diet increases
atherosclerosis(9), and epidemiological studies have shown
an association between plasma oxycholesterols and CVD(10).
Oxycholesterols have also shown to possess mutagenic and
carcinogenic effects in both in vivo and in vitro studies(11).
The typical Western diet contains substantial quantities of
oxidised cholesterol, and the mean dietary intake has been
estimated in mg/d per person(12).
In view of the health implications of oxycholesterol
absorption from food, we investigated, in a pilot study, the
possibility that wine consumption with a meal influences the
postprandial increase in plasma lipid hydroperoxides and
oxycholesterols in humans.
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Subjects and study design
A total of twelve volunteers (six males and six females, age 24–
35 years) participated in a cross-over study. Subjects, free from
known diseases, were asked to keep their diet as constant as
possible during the study period, and none of them was
taking any drugs or vitamin supplement. The present study
was conducted according to the guidelines laid down in the
Declaration of Helsinki, and all procedures involving human
subjects were approved by the Ethical Committee of the
National Institute for Food and Nutrition Research. Verbal
informed consent was obtained from all subjects; verbal con-
sent was witnessed and formally recorded. Subjects ate the
same test meal in two different sessions (2 weeks apart) after
a 10–12 h fasting interval. The test meal, a double cheeseburger,
was eaten with 300 ml of water (control) or with 300 ml of red
wine (Teroldego Rotaliano, Foradori, 2004). The cheeseburger
weighed approximately 200 g and contained 25·7 g of protein,
25·9 g of lipid (10·5 g SFA, 8·6 g MUFA and 0·8 g PUFA), 34·3 g
of carbohydrate and 83 mg of cholesterol (US Department of
Agriculture food composition table). The alcoholic grade of
wine was 13·3 %, with pH 3·71, total SO2 66 mg/l, and its pheno-
lic content was assessed as reported by Canali et al.(13), with the
exception of flavanols, which were estimated by LC–MS
according to Mattivi et al.(14).
Plasma and meal analyses
Blood was collected before (time 0) and 1 and 3 h after the
meal. Venous blood samples were collected into vacutainers
containing opportune anticoagulants. Plasma samples were
separated by centrifugation and stored at 2808C until anal-
ysis. Plasma total cholesterol, TAG and alcohol were
measured by commercial kits (Futura System Srl, Formello,
Roma, Italy; Sigma, St Louis, MO, USA). Plasma samples for
the determination of oxycholesterols were stored at 2808C,
after the addition of butylated hydroxytoluene (50mg/ml),
and analysed within 2 weeks. Total lipid hydroperoxides
were measured in plasma by the ferrous ion oxidation xyle-
nol orange-2 assay, as described by Nourooz-Zadeh(15).
Cheeseburger samples were analysed with the same
methods described for plasma after homogenisation and
extraction with chloroform–methanol(16).
Oxycholesterol measurement
The following four different oxycholesterols were measured
in both the meal and plasma: 7-ketocholesterol (7-Keto-C),
5a,6a-epoxycholesterol, 5b,6b-epoxycholesterol and 7b-
hydroxycholesterol by GC–MS(17).
The four oxycholesterols were selected because they are the
most abundant in food and efficiently absorbed(18).
Briefly, plasma samples (200ml) were added with 1mg of
the internal standard (19-hydroxycholesterol). Saponification
was carried out under N2 flow at 608C for 90 min with 1 ml
of 1 M-NaOH ethanolic solution. Samples were then extracted
with cyclohexane, and the resulting organic layer was
evaporated to dryness under N2. Then, they were resuspended
in 1 ml hexane and applied to solid-phase extraction (Supel-
clean Lc-Si cartridge; Sigma)(19). The oxycholesterol fraction
was dried under N2 and derivatised with 70ml of the Sylon
BTZ kit (at room temperature for 45 min). GC–MS analyses
were performed on an Agilent 6850A gas chromatograph
coupled to a 5973N quadrupole mass-selective detector
(Agilent Technologies, Palo Alto, CA, USA). Gas chromato-
graphic separations were carried out on an Agilent HP-5MS
fused silica capillary column (inner diameter 30 m £ 0·25 mm
and film thickness 0·25mm). The injection mode was splitless
at a temperature of 2808C. The column temperature pro-
gramme was as follows: 1608C (1 min) to 2808C at a rate of
208C/min and held for 15 min. The carrier gas was He at a con-
stant flow of 1·0 ml/min. The spectra were obtained in elec-
tron impact mode at 70 eV ionisation energy; ion source
temperature was 2808C and ion source vacuum was 1025
Torr (1·3 £ 1023 Pa). Analyses were performed both in total
ion current and selected-ion monitoring modes. Selected-ion
monitoring analyses were carried out by selecting the follow-
ing representative ions: m/z 353 for the 19-OH-C trimethylsilyl
(TMS) derivative; m/z 456 for the 7b-hydroxycholesterol TMS
derivative; m/z 474 for the 5b,6b-epoxycholesterol TMS
derivative; m/z 474 for the 5a,6a-epoxycholesterol
TMS derivative; m/z 472 for the 7-Keto-C TMS derivative.
Statistical analysis
Data are presented as means and standard deviations.
Statistical analysis was carried out using repeated-measures
ANOVA, followed by Tukey’s test for multiple comparisons.
Analyses were performed with KaleidaGraph software (ver-
sion 3.6; Synergy Software, Reading, PA, USA). P values
,0·05 were considered statistically significant.
Results
Wine composition
Total polyphenols (1871 mg/l, as catechin equivalents) were in
the typical range for the variety. The concentration of total
proanthocyanidins was 167·7 mg/l. The total administered
dose of the major phenolics was calculated from the concen-
tration in wine measured by HPLC at the time of the exper-
iment. The wine had a quite high content of free
anthocyanins, and the total administered dose was of
304·1mmol. Hydroxycinnamates (85·2mmol administered)
consisted mainly of trans-caftaric acid, coutaric acid and
trans-coumaric acid, with minor amounts of fertaric acid and
grape reaction product (i.e. trans-2-S-glutathionyl-
caftaric acid). Free flavanols (total of 82·9mmol) consisted of
epigallocatechin, (þ)-catechin, epicatechin and gallocatechin.
Myricetin was by far the main flavonol (20·5mmol of total fla-
vonols). Other minor phenolics were tyrosol (29·8mmol) and
the four monomers of resveratrol (for a total of 5·4mmol).
In summary, the single dose of Teroldego wine provided
561 mg of phenolics (which is approximately in the millimolar
level, assuming an average molecular weight of 500).

















Lipid hydroperoxides and oxycholesterols in the test meal
The lipid hydroperoxide content of the test meal was 237
(SD 36)mmol of H2O2 equivalents.
As for oxycholesterols, the test meal contained 498 (SD
147)mg of 7-ketocholesterol, 138 (SD 48)mg of 5a,6a-epoxy-
cholesterol, 91 (SD 6)mg of 7b-hydroxycholesterol and 70
(SD 6)mg of 5b,6b-epoxycholesterol.
When expressed per g of the test meal, total oxycholesterols
were 3·9 (SD 1·1)mg/g, and this value is in accordance with
literature data. van de Bovenkamp et al.(12) reported 3·6mg
of total oxycholesterols/g of a cooked mixed Dutch diet,
while Baggio et al.(20) and Rodriguez-Estrada et al.(21) reported
a concentration of about 2mg/g of hamburger.
Effect of the control and wine meals on plasma lipids, lipid
hydroperoxides and oxycholesterols
Plasma concentrations of total cholesterol, TAG and alcohol,
before and after the control and wine meals, are shown in
Table 1. As expected, there was an increase in plasma TAG
after the consumption of both meals, while ethanol, as
expected, increased significantly only after the wine meal.
Cholesterol concentration did not change significantly after
both meals.
As shown in Fig. 1, the control meal induced a significant
increase in total plasma lipid hydroperoxides. On the contrary,
the wine meal not only prevented this increase, but also
reverted it, inducing a significant decrease in plasma lipid
hydroperoxides.
Fig. 1 shows also the effect of the meal on plasma oxycho-
lesterols. The control meal induced a significant increase in
7b-hydroxycholesterol and 7-ketocholesterol concentrations.
This increase was statistically significant 1 h after the con-
sumption of the meal. The postprandial increase in these
two oxycholesterols was fully prevented when wine was
consumed with the meal. Indeed, wine consumption induced
a significant decrease in 7b-hydroxycholesterol. Both 5a,6a-
epoxycholesterol and 5b,6b-epoxycholesterol showed the
same trend as observed for 7b-hydroxycholesterol and 7-
ketocholesterol, even if their postprandial changes (after both
the control and wine meals) were not statistically significant.
An estimation based on the subjects’ volume of plasma
(55 % of volume of blood, calculated individually as 7 % of
their body weight(22)) indicates that total plasma oxycho-
lesterols (the sum of the measured four oxycholesterols)
represented 105 (SD 29) and 95 (SD 26) % of the ingested
dose 1 and 3 h after the control meal, respectively. As evident
from Fig. 1, after the wine meal, total plasma oxycholesterols
decreased below the baseline value (255 (SD 28) and 231 (SD
41) % of the ingested dose, at 1 and 3 h, respectively).
Discussion
Some authors suggest that the absorption from meals of the
products of lipid oxidation could be, at least partially, the
link between postprandial lipaemia and atherosclerosis(23).
Oxycholesterols are a common component of the Western
diet, and their presence is striking in fast food and processed
food. Studies in both humans(18) and animals(24) have demon-
strated that oxycholesterols are absorbed by the small intestine,
transported in plasma by chylomicrons and incorporated into
lipoprotein. As oxycholesterols posses several proatherogenic
activities(8), a delayed clearance of these compounds from the
circulation could be harmful.
Although oxysterols are principally derived from dietary
sources, circulating oxycholesterols may be produced
enzymatically at the intracellular level and/or from lipopro-
tein oxidation into the circulation(25), or by free radical-
catalysed oxidation of cholesterol during digestion, both at
gastric(4,26) and intestinal levels(27). Even if oxycholesterols
have a faster plasma clearance than ‘normal’ cholesterol, the
level of oxycholesterols in plasma can remain elevated for
more than 6–8 h after a meal(18). Thus, the frequent consump-
tion of foods rich in oxycholesterols can result in a continuous
exposure during most of the day.
According to the literature, the estimates of the extent to
which oxycholesterols are absorbed vary from 6 to 93 %(28).
This wide range of results may be due to both the dose and
vehicle used to administer the oxycholesterols(28). Our estimate
seems to indicate a complete absorption (105 (SD 29) % of the
ingested dose) 1 h after the control meal. We hypothesise, how-
ever, that some of the oxycholesterols present in plasma derive
from the oxidation of the cholesterol contained in the meal
during the digestive process. Although the formation of oxycho-
lesterols during digestion cannot be demonstrated by the pre-
sent study design, several authors provide evidence that lipid
oxidation can occur during digestion(26,27,29), and that the
presence of antioxidants in the digestive tract can protect
from this event(26,30).
A few animal studies have demonstrated that supple-
mentation with antioxidants can prevent the increase in
Table 1. Plasma concentration of some metabolic parameters in plasma after a double cheeseburger meal with 300 ml of water or wine
(Mean values and standard deviations, n 12)
Control Wine
0 1 h 3 h 0 1 h 3 h
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Total cholesterol (mg/l) 1630 300 1650 260 1610 300 1660 250 1640 270 1660 260
TAG (mg/l) 820 160 820* 240 1070* 330 670 210 970 530 1230* 240
Alcohol (%, w/v) 0·01 0·01 0·01 0·01 0·01 0·01 0·01 0·01 0·08* 0·03 0·05* 0·02
* Mean values were significantly different from those of homologous time 0: P,0·005 (by repeated-measures ANOVA, followed by Tukey’s test).

















circulating oxycholesterols induced by a high-fat diet(31), while
the addition of pro-oxidant species to the diet results in a drastic
increase in hepatic oxycholesterols(32). Finally, some human
studies have demonstrated that long-term supplementation of
antioxidants can reduce the plasma level of oxycholesterols(33).
Thus, the composition of diet (its antioxidant/pro-oxidant
balance) has a great influence on the circulating level of
oxycholesterols.
However, in all these studies, the effects of antioxidants on
the circulating level of oxycholesterols have been studied after
a chronic supplementation with a high-fat diet. The present
study, instead, demonstrates that wine could prevent the
acute oxycholesterol ‘toxicity’ induced by a single high-fat
meal.
It has been demonstrated that wine or wine polyphenols
consumption can hinder many harmful postprandial events,
such as oxidative stress and endothelial dysfunction. Red
wine consumption with the meal reduces the susceptibility
to oxidation of postprandial LDL(3) and prevents the post-
prandial increase in plasma lipid hydroperoxides and malon-
dialdehyde(4). A standardised grape product suppresses the
meal-induced impairment of vascular endothelial function(34).
In the present study, we have demonstrated for the first time
that a glass of wine can prevent the postprandial increase in
plasma lipid hydroperoxides and oxycholesterols after the
ingestion of a high-fat, high-cholesterol meal. The peak point
seems to correspond to 1 h, but our experimental design (last
point 3 h after the meal) cannot indicate the length of the
effect; this is a limitation of the present study.
Epidemiological studies have indicated a J-shaped relation-
ship between wine consumption and CVD risk(35). The shape
of the curve is the result of the opposite effects of wine/
alcohol on the cardiovascular system: ‘positive’, such as an
increase in HDL-cholesterol, anti-thrombotic effects, improved
endothelial function, reduced insulin resistance, etc. and
‘negative’, such as an increase in postprandial TAG level
(that is evident also from our data, see TAG in Table 1) and
induction of lipid peroxidation by ethanol.
In this view, the postprandial reduction in oxycholesterols
and oxidised lipids could represent a further ‘positive’ effect of
wine. It is well known, in fact, that oxysterols are present in
atherosclerotic lesions(36–38) and atherogenic lipoprotein(39),
and possess several proatherogenic activities, such as cytotox-
icity on endothelial and arterial smooth muscle cells, down-
regulation of LDL receptors on vascular cell, proinflammatory
activities (induction of cytokine release by macrophages and
of the expression of adhesion molecule in endothelial
cells)(40–45). Finally, several animal studies have shown that oxy-
cholesterols promote the onset and the development of athero-
sclerosis(9,46,47).
The results of the present pilot study do not allow
explanation of the mechanisms/reactions by which wine
counteracts the postprandial increase in circulating
oxidised lipids, so that we can just speculate on some possibi-
lities, needing experimental confirmation.
Wine polyphenols and/or alcohol could minimise the post-
prandial increase in plasma lipid hydroperoxides and choles-
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Fig. 1. Time course of plasma (a) lipid hydroperoxides and oxycholesterols ((b) 7-ketocholesterol, (c) 7-b-hydroxycholesterol, (d) 5a,6a-epoxycholesterol and
(e) 5b,6b-epoxycholesterol) after the administration of the control meal (—) or wine meal (· · ·). Values are means, with standard errors represented by vertical
bars (n 12). Mean values were significantly different from those of homologous time 0: *P,0·05 and **P,0·01 (by repeated-measures ANOVA, followed by
Tukey’s test).

















products or preventing their formation in the digestive tract(26),
(2) preventing or delaying fat absorption(48–50), (3) inducing
detoxifying enzymes in the gut and liver(51,52), (4) enhancing
the cholesterol oxidation product clearance, through the
induction of enzymes involved in the cholesterol catabolism
towards bile acids(53,54) and (5) chemically reducing lipid
hydroperoxide and/or oxycholesterols into the circulation
after their absorption.
We studied the effect of wine as a whole, thus we cannot
determine which is the wine component (alcohol or polyphe-
nols) responsible for the observed effects and whether other
forms of alcoholic beverages could have similar effects. This
matter is definitely very interesting, and it should be the
object of further investigation. Similarly, it should be important
to study how a different ratio of wine:meal oxycholesterols
could affect the wines capacity to cope with the increase in
plasma oxycholesterols.
The present study provides evidence that consumption of
wine with a meal could prevent and ‘counterattack’ the post-
prandial increase in plasma lipid hydroperoxides and oxycho-
lesterols, thus protecting the organism from their potential
proatherogenic effect. In this view, the controversial effect of
a moderate wine consumption on ‘health’ (different effects v.
different diseases) could be revised, as the modality of drinking
wine (either during or separately from the meal) could rep-
resent a decisive factor.
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